Hanieh Moshayedi1, Oluwaseun A Omofoye2, Edward Yap3, Taofik O Oyekunle4, Deanna M Sasaki-Adams3, Sten Y Solander1. 1. Division of Interventional Neuroradiology, Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. 2. Department of Neurosurgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Electronic address: oomofoye@gmail.com. 3. Department of Neurosurgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. 4. Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Abstract
OBJECTIVE: To evaluate the clinical and angiographic outcomes of intracranial aneurysm treatment using a single Pipeline embolization device (PED), and to evaluate the factors affecting aneurysm obliteration rate. METHODS: The demographic characteristics and anatomic features of 58 aneurysms in 47 patients treated with a single PED were reviewed retrospectively. All aneurysms treated with a PED at a single center and with follow-up angiograms for at least 6 months were included in this study. RESULTS: The overall rate of complete and near-complete occlusion was 84% (49 of 58) after a mean follow-up period of 18.3 months. The rate of complete aneurysm obliteration was lower in aneurysms with an arterial branch arising from the aneurysm neck compared with aneurysms without an arterial branch (13% [1 of 8] vs. 68% [34 of 50]; P = 0.0075). The overall rate of complete and near-complete aneurysm occlusion was 90% (45 of 50) in aneurysms without an arterial branch arising from its neck. There were no statistically significant associations between obliteration rate and aneurysm neck width, size, or type, or history of previous coil embolization. CONCLUSIONS: Our data suggest that a single PED is sufficient to induce complete or near-complete obliteration of most aneurysms. The presence of a branching artery arising from the aneurysm neck is highly predictive of incomplete occlusion after treatment with a single PED.
OBJECTIVE: To evaluate the clinical and angiographic outcomes of intracranial aneurysm treatment using a single Pipeline embolization device (PED), and to evaluate the factors affecting aneurysm obliteration rate. METHODS: The demographic characteristics and anatomic features of 58 aneurysms in 47 patients treated with a single PED were reviewed retrospectively. All aneurysms treated with a PED at a single center and with follow-up angiograms for at least 6 months were included in this study. RESULTS: The overall rate of complete and near-complete occlusion was 84% (49 of 58) after a mean follow-up period of 18.3 months. The rate of complete aneurysm obliteration was lower in aneurysms with an arterial branch arising from the aneurysm neck compared with aneurysms without an arterial branch (13% [1 of 8] vs. 68% [34 of 50]; P = 0.0075). The overall rate of complete and near-complete aneurysm occlusion was 90% (45 of 50) in aneurysms without an arterial branch arising from its neck. There were no statistically significant associations between obliteration rate and aneurysm neck width, size, or type, or history of previous coil embolization. CONCLUSIONS: Our data suggest that a single PED is sufficient to induce complete or near-complete obliteration of most aneurysms. The presence of a branching artery arising from the aneurysm neck is highly predictive of incomplete occlusion after treatment with a single PED.
Authors: Nohra Chalouhi; Robert M Starke; Steven Yang; Cory D Bovenzi; Stavropoula Tjoumakaris; David Hasan; L Fernando Gonzalez; Robert Rosenwasser; Pascal Jabbour Journal: Stroke Date: 2013-11-19 Impact factor: 7.914
Authors: Badih Daou; Robert M Starke; Nohra Chalouhi; Stavropoula Tjoumakaris; Jean Khoury; David Hasan; Robert H Rosenwasser; Pascal M Jabbour Journal: Neurosurgery Date: 2015-11 Impact factor: 4.654
Authors: S A Scott; K Sangkuhl; C M Stein; J-S Hulot; J L Mega; D M Roden; T E Klein; M S Sabatine; J A Johnson; A R Shuldiner Journal: Clin Pharmacol Ther Date: 2013-05-22 Impact factor: 6.875
Authors: Leonardo Rangel-Castilla; Stephan A Munich; Naser Jaleel; Marshall C Cress; Chandan Krishna; Ashish Sonig; Kenneth V Snyder; Adnan H Siddiqui; Elad I Levy Journal: J Neurosurg Date: 2016-06-10 Impact factor: 5.115
Authors: Anderson Chun On Tsang; Arthur Man Yuen Fung; Frederick Chun Pong Tsang; Gilberto Ka Kit Leung; Raymand Lee; Wai Man Lui Journal: Neurointervention Date: 2015-09-02
Authors: Justin E Vranic; Pablo Harker; Christopher J Stapleton; Robert W Regenhardt; Adam A Dmytriw; Naif M Alotaibi; Rajiv Gupta; Thabele M Leslie-Mazwi; Matthew J Koch; Scott B Raymond; Justin R Mascitelli; T Tyler Patterson; Joshua Seinfeld; Andrew White; David Case; Christopher Roark; Chirag D Gandhi; Fawaz Al-Mufti; Jared Cooper; Aman B Patel Journal: Neuroradiol J Date: 2021-11-07
Authors: T Sunohara; H Imamura; M Goto; R Fukumitsu; S Matsumoto; N Fukui; Y Oomura; T Akiyama; T Fukuda; K Go; S Kajiura; M Shigeyasu; K Asakura; R Horii; C Sakai; N Sakai Journal: AJNR Am J Neuroradiol Date: 2020-11-12 Impact factor: 3.825